Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026
By Sahil Pandey July 20 (Reuters) – Scholar Rock said on Monday a European Union opinion on its experimental spinal muscular atrophy treatment could be pushed to later this year, as regulators await the U.S. FDA’s classification of a manufacturing facility included in the drug developer’s European f























